Drugs / PARENT OF BMS-986202
last change Dec 2016 re-read 2 minutes ago

PARENT OF BMS-986202

also known as BMS-986202

Small molecule

Developed for
psoriasis
Investigated by
Bristol-Myers Squibb

Trials 1 · a red edge is where a trial was stopped

2017201820192020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT02763969 May → Dec 2016 psoriasis Bristol-Myers Squibb Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as PARENT OF BMS-986202 ChEMBL registry synonym — accepted as the source's own label CHEMBL4803710
Known as BMS-986202 ClinicalTrials.gov intervention name — accepted as the source's own label NCT02763969
Modality Small molecule CHEMBL4803710